LeMaitre Vascular, Inc. (LMAT) — Analysis Summary
LeMaitre Vascular, Inc. (LMAT) has a market cap of $1.90B with year-over-year revenue growth of +13.5%. Net margin stands at 23.1%. The stock trades at a P/E ratio of 28.9.
Key Takeaways
- Revenue changed +13.5% year-over-year
- Net margin of 23.1%
- P/E ratio of 28.9
Compared to other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, LMAT posted revenue growth of +13.5% and trades at a P/E of 28.9.
LeMaitre Vascular, Inc. (LMAT)
PREVIOUS CLOSE 2026-10-12 · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsNo Major Flags
No major credit, margin, or trend red flags were triggered from the latest filings.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees
655
Headquarters
BURLINGTON, MA
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Annual Dividend/Share
$1.00
Dividend Yield
1.21%
Dividend History
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.